Correspondence to Distinguished Professor Charlie C Xue, School of Health and Biomedical Sciences, RMIT University, Melbourne, Victoria, Australia; charlie.xue{at}rmit.edu.au; Professor Lin Lin, The ...

Spirometry phenotypes at 8 years in children born extremely preterm or with extremely low birth weight ...

1 NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust and Imperial College, Harefield, UK 2 Harefield Pulmonary Rehabilitation Unit, Royal Brompton & Harefield ...

Background Numerous studies have found associations between parental socio-economic position (SEP) and offspring asthma.

Correspondence to Henrik Johansson, Department of Neuroscience/Physiotherapy, Uppsala University, Box 593 BMC, Uppsala 751 24, Sweden; henrik.johansson{at}neuro.uu.se ...

Background Risk factors for COPD in high-income settings are well understood; however, less attention has been paid to contributors of COPD in low-income and middle-income countries (LMICs) such as ...

Individuals born extremely preterm (EP-born) must complete lung development outside the uterus, affecting the maturation and growth of airways and alveoli. They often show signs of both obstructive ...

A 13-year-old boy with primary ciliary dyskinesia (PCD) had progressive severe cystic bronchiectasis of the left middle and lower lobes on serial CT scans, in the context of situs inversus totalis and ...

1 Nottingham Respiratory Research Unit, University of Nottingham, City Hospital, Nottingham, UK 2 Epidemiology and Public Health, University of Nottingham, City Hospital, Nottingham, UK 3 Respiratory ...

The number of asthma deaths among children and young people (CYP) in the UK has remained stubbornly constant despite advances in medication, delivery systems and maintenance and reliever therapy ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Background Compared with cytotoxic chemotherapy, the efficacy and safety of immune checkpoint inhibitors (ICIs) for patients with interstitial lung disease and non-small cell lung cancer (ILD-NSCLC) ...